GGrantIndex
Sort

64,565 grants matching drug discovery

Illuminating the Druggable Genome by Knowledge Graphs

$536,615
Peter Nicholas Robinson · Jackson Laboratory · U01 · FY2021 · CA

Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC

$536,596
Francis X McCormack · University Of Cincinnati · U01 · FY2021 · HL

Validation and development of trypanosomal phosphodiesterase inhibitors for treat

$536,539
Michael P Pollastri · Northeastern University · R01 · FY2010 · AI

Defining a pathway for mitochondrial heme trafficking

$536,531
Dennis J Stuehr · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · GM

Global Alzheimer’s and Dementia Partnership to Advance Neuroscience in LMICs (GAP-ADN)

$536,527
Margaret A Pericak-Vance · University Of Miami School Of Medicine · U24 · FY2025 · AG

Orally Active Nucleoside Phosphonates for Hepatitis C Virus

$536,480
Robert Turner Schooley · University Of California, San Diego · R01 · FY2010 · AI

CHEMOPROTEOMIC METHODS FOR SERINE HYDROLASE INHIBITOR DEVELOPMENT

$536,462
Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2018 · DA

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma

$536,425
Yuan Chen · University Of California, San Diego · R01 · FY2021 · CA

Targeting myocardial fibrosis with a novel noncoding RNA in Duchenne muscular dystrophy

$536,402
Russell Rogers · Cedars-Sinai Medical Center · R01 · FY2025 · HL

Rational Design of Antibiotics Targeted at the Ribosome

$536,400
Anadys Pharmaceuticals, Inc. · R44 · FY2004 · AI

Mapping the Secondary Metabolomes of Marine Cyanobacteria

$536,296
William H Gerwick · University Of California, San Diego · R01 · FY2016 · GM

Adiponectin, A Protein Secreted From Adipose Tissue

$536,280
Philipp E Scherer · Ut Southwestern Medical Center · R01 · FY2020 · DK

Development of STEP substrates and probes as novel tools and therapeutics for Alzheimer's disease

$536,250
Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2020 · AG

"Infection and Inflammation in Atherosclerosis"

$536,226
Salomon Amar · New York Medical College · R01 · FY2017 · HL

Attention and Executive Functioning in Aging and Parkisonism

$536,204
Jay S Schneider · Thomas Jefferson University · R01 · FY2010 · NS

Preclinical Pharmacological Studies

$536,046
Kenneth Chan · Ohio State University · N01 · FY2009 · CA

T CRUZI GENOME: UU

$535,999
Karolinska Institute · U01 · FY2003 · AI

Novel Enediyne-Based Antibody-Drug Conjugates for Cancers

$535,980
Ben Shen · Scripps Florida · R01 · FY2021 · CA

Vibrational Spectroscopic Imaging to Unveil Hidden Signatures in Living Systems

$535,971
Ji-Xin Cheng · Boston University (Charles River Campus) · R35 · FY2020 · GM

Developmental Funds

$535,817
Jennifer A Pietenpol · Vanderbilt University · P30 · FY2010 · CA

Drug Discovery Group for Nicotine Dependence Treatment

$535,800
Maurizio Fava · Massachusetts General Hospital · U01 · FY2009 · DA

Defined microbial communities to prevent and eradicate infection by AMR pathogens

$535,780
Robert A Britton · Baylor College Of Medicine · U19 · FY2024 · AI

Epidemiologic Studies

$535,777
Stephen B Gruber · University Of Southern California · U19 · FY2013 · CA

Hydronic, High-Speed, Focal Thermal Stimulator

$535,762
Ala Scientific Instruments, Inc. · R42 · FY2005 · NS

Target Specificity of Tabernanthalog Treatment in Opioid Use Disorder

$535,758
Jamie L Peters · University Of Alabama At Birmingham · R01 · FY2025 · DA